Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

Journal:
The Lancet
Published:
Affiliations:
29
Authors:
436
Institutions Authors Share
Population Health Research Institute (PHRI), Canada
7.500000
0.25
McMaster University, Canada
3.500000
0.12
Universidad Tecnológica Equinoccial (UTE), Ecuador
2.000000
0.07
St. John's Medical College, India
2.000000
0.07
Hospital Angelina Caron, Brazil
1.000000
0.03
Centro de Asistencia del Sindicato Médico del Uruguay (CASMU), Uruguay
1.000000
0.03
Peking University People's Hospital, PKUHSC, China
1.000000
0.03
Hospital Sultanah Aminah (HSA), Malaysia
1.000000
0.03
Madras Medical College, India
1.000000
0.03
University of Glasgow, United Kingdom (UK)
1.000000
0.03
Philippine General Hospital (PGH), Philippines
1.000000
0.03
Hacettepe University, Turkey
1.000000
0.03
The George Institute for Global Health (TGI), Australia
0.833333
0.03
University of New South Wales (UNSW Sydney), Australia
0.750000
0.03
Dalhousie University, Canada
0.500000
0.02
Nova Scotia Health Authority (NSHA), Canada
0.500000
0.02
St. Michael's Hospital, Canada
0.500000
0.02
Waitemata District Health Board, New Zealand
0.500000
0.02
University of Alberta (U of A), Canada
0.500000
0.02
Pontifical Catholic University of Minas Gerais (PUC Minas), Brazil
0.500000
0.02
The University of Auckland, New Zealand
0.500000
0.02
Tel Aviv Sourasky Medical Center, Israel
0.500000
0.02
Concord Repatriation General Hospital (CRG), USYD, Australia
0.333333
0.01
Macquarie University, Australia
0.333333
0.01
The George Institute - India (TGI India), India
0.250000
0.01
Imperial College London (ICL), United Kingdom (UK)
0.250000
0.01
Manipal Academy of Higher Education (MAHE), India
0.250000
0.01